Search by Drug Name or NDC
NDC 11673-0052-54 Target Antacid - Anti-Gas Relief Chews 750; 80 mg/1; mg/1 Details
Target Antacid - Anti-Gas Relief Chews 750; 80 mg/1; mg/1
Target Antacid - Anti-Gas Relief Chews is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Target. The primary component is CALCIUM CARBONATE; DIMETHICONE.
MedlinePlus Drug Summary
Calcium carbonate is a dietary supplement used when the amount of calcium taken in the diet is not enough. Calcium is needed by the body for healthy bones, muscles, nervous system, and heart. Calcium carbonate also is used as an antacid to relieve heartburn, acid indigestion, and upset stomach. It is available with or without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 11673-0052-54Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Calcium Carbonate
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 11673-0052-54Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Simethicone
Product Information
NDC | 11673-0052 |
---|---|
Product ID | 11673-052_06d27bcc-fba5-4884-e063-6294a90aa2fe |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Target Antacid - Anti-Gas Relief Chews |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Calcium Carbonate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 750; 80 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | CALCIUM CARBONATE; DIMETHICONE |
Labeler Name | Target |
Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part331 |
Listing Certified Through | 2024-12-31 |
Package
NDC 11673-0052-54 (11673005254)
NDC Package Code | 11673-052-54 |
---|---|
Billing NDC | 11673005254 |
Package | 54 TABLET, CHEWABLE in 1 BOTTLE (11673-052-54) |
Marketing Start Date | 2019-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |